The Full‐Length Genomic Sequence of the HLA ‐B*39:130 Allele
HLA · 2024
DOI: 10.1111/tan.15769 ↗Kurz gefasst
Fachartikel in der Zeitschrift HLA, 2024. Verfasst von LiXin Li und 1 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Cellular and Molecular Biology, College of Basic Medical Sciences, Central South University, Changsha, Hunan, China. Hauptthemen laut MEDLINE: Alleles, Introns, Base Sequence. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 5 Literaturangaben. Gefördert von: Changsha Municipal Natural Science Foundation.
Abstract (Originalsprache)
HLA‐B*39:130 differs from HLA‐B*39:01:01:01 at codon 214 (ACA → ATA) and position 355 (T → C) in intron 5.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Cellular and Molecular Biology, College of Basic Medical Sciences, Central South University, Changsha, Hunan, China.
- Immunogenetics Research Group, Department of Immunology, College of Basic Medical Sciences, Central South University, Changsha, Hunan, China.
ORCID-Profile: Wei Tian
Förderung
- Changsha Municipal Natural Science Foundation
Zitieren
APA
Li, L., & Tian, W. (2024). The Full‐Length Genomic Sequence of the HLA ‐B*39:130 Allele. HLA. https://doi.org/10.1111/tan.15769
Vancouver
Li L, Tian W. The Full‐Length Genomic Sequence of the HLA ‐B*39:130 Allele. HLA. 2024. doi:10.1111/tan.15769
BibTeX
@article{Li2024,
author = {Li, LiXin and Tian, Wei},
title = {The Full‐Length Genomic Sequence of the HLA ‐B*39:130 Allele},
journal = {HLA},
year = {2024},
doi = {10.1111/tan.15769}
}
EUVIMED